Tag Archives: rare disease

Employer Plans View Product Coverage Very Differently from PBMs

Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies

Did You Know Market Access is Closing Down

Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs

Independence Blue Cross Launches Gene Therapeutics Network

BlueCross Blue Shield Plans: Access Market Intelligence

Independence Blue Cross (Independence) recently announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023

Corcept Therapeutics Extends Exclusive Specialty Pharmacy Distribution Agreement for Korlym with Optime Care

Corcept Therapeutics Extends Exclusive Specialty Pharmacy Distribution Agreement for Korlym with Optime Care

AscellaHealth Offering Robust Commercialization and Market Access Services

AscellaHealth’s comprehensive portfolio of services results in streamlined access to therapy, optimal clinical results and an enhanced patient journey

QOL Medical Selects Optum Frontier Therapies as New Partner for Sucraid®

QOL Medical Selects Optum Frontier Therapies as New Pharmacy Partner for Sucraid® to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution

United BioSource Expands Capabilities for Biopharmaceutical Clients

This year, UBC has partnered with Seqster and acquired Marketshare Movers to advance the company’s capabilities in clinical trials and co-pay and affordability programs

Biologics by McKesson Selected to Provide VONJO and PYRUKYND

Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market